Susquehanna International Group
AMPE

Susquehanna International Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Susquehanna International Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-289,600
Closed -$594K – 13872
2023
Q4 		$594K Hold
289,600
– – ﹤0.01% 8241
2023
Q3 		$1.05M Buy
289,600
+275,120
+1,900% +$1.19M ﹤0.01% 6520
2023
Q2 		$66.6K Hold
14,480
– – ﹤0.01% 11206
2023
Q1 		$66.6K Sell
14,480
-23,090
-61% -$130K ﹤0.01% 11555
2022
Q4 		$173K Buy
37,570
+35,018
+1,372% +$226K ﹤0.01% 10326
2022
Q3 		$46K Sell
2,552
-192
-7% -$6.72K ﹤0.01% 12261
2022
Q2 		$140K Sell
2,744
-288
-9% -$21.4K ﹤0.01% 11116
2022
Q1 		$428K Buy
3,032
+1,122
+59% +$164K ﹤0.01% 9378
2021
Q4 		$327K Buy
1,910
+617
+48% +$230K ﹤0.01% 10274
2021
Q3 		$644K Sell
1,293
-80
-6% -$37.1K ﹤0.01% 8728
2021
Q2 		$688K Sell
1,373
-395
-22% -$212K ﹤0.01% 8787
2021
Q1 		$896K Buy
1,768
+313
+22% +$161K ﹤0.01% 8021
2020
Q4 		$694K Buy
1,455
+627
+76% +$206K ﹤0.01% 7566
2020
Q3 		$238K Sell
828
-383
-32% -$94.9K ﹤0.01% 9166
2020
Q2 		$231K Buy
1,211
+29
+2% +$4.82K ﹤0.01% 8795
2020
Q1 		$147K Buy
1,182
+1,139
+2,649% +$206K ﹤0.01% 9010
2019
Q4 		$7K Sell
43
-119
-73% -$15.4K ﹤0.01% 9571
2019
Q3 		$24K Sell
162
-493
-75% -$65.7K ﹤0.01% 9927
2019
Q2 		$76K Buy
655
+211
+48% +$33.4K ﹤0.01% 9717
2019
Q1 		$75K Sell
444
-223
-33% -$38.2K ﹤0.01% 8353
2018
Q4 		$79K Sell
667
-89
-12% -$13.7K ﹤0.01% 8320
2018
Q3 		$115K Buy
756
+685
+965% +$286K ﹤0.01% 8551
2018
Q2 		$47K Sell
71
-966
-93% -$723K ﹤0.01% 9294
2018
Q1 		$1.06M Buy
1,037
+387
+60% +$324K ﹤0.01% 5116
2017
Q4 		$794K Buy
+650
New +$306K ﹤0.01% 5708
2017
Q3 		– Sell
-168
Closed -$26K – 9886
2017
Q2 		$26K Buy
168
+80
+91% +$16.2K ﹤0.01% 8989
2017
Q1 		$21K Buy
+88
New +$23.7K ﹤0.01% 8725
2016
Q3 		– Sell
-258
Closed -$100K – 9252
2016
Q2 		$100K Sell
258
-47
-15% -$51.3K ﹤0.01% 8017
2016
Q1 		$206K Buy
305
+109
+56% +$73.4K ﹤0.01% 7921
2015
Q4 		$206K Buy
196
+40
+26% +$39.6K ﹤0.01% 8378
2015
Q3 		$135K Buy
156
+36
+30% +$30.1K ﹤0.01% 8987
2015
Q2 		$91K Sell
120
-484
-80% -$516K ﹤0.01% 9707
2015
Q1 		$1.36M Buy
604
+349
+137% +$595K ﹤0.01% 5126
2014
Q4 		$263K Sell
255
-99
-28% -$106K ﹤0.01% 8357
2014
Q3 		$375K Sell
354
-309
-47% -$520K ﹤0.01% 7700
2014
Q2 		$1.66M Buy
663
+421
+174% +$859K ﹤0.01% 5016
2014
Q1 		$462K Buy
+242
New +$572K ﹤0.01% 6864
2013
Q4 		– Sell
-515
Closed -$1.16M – 9464
2013
Q3 		$1.16M Buy
515
+473
+1,126% +$915K ﹤0.01% 5031
2013
Q2 		$73K Buy
+42
New +$66.7K ﹤0.01% 7883

Other funds holding AMPE

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's AMPE Position: Q1 2024 in Review

Susquehanna International Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2024, closing a stake of 19,580 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in AMPE in Q3 2013 and held it in 32 quarters. The position peaked at $3.18M in Q3 2013. 28 funds tracked by Wall St. Rank hold AMPE as of Q1 2024.

  • Susquehanna International Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 19,580 Ampio Pharmaceuticals Inc. shares in Q1 2024, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 32 quarters.
  • Susquehanna International Group's Ampio Pharmaceuticals Inc. position peaked at $3.18M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.